Cohance Lifesciences Ltd (COHANCE) โ Board Meeting | 18 September 2026
Cohance Lifesciences invested USD 10 million in newly issued Compulsorily Convertible Preferred Stock (CCPS) of its subsidiary NJ Bio Inc., USA, completing the subscription in September 2026. The investment, made through internal accruals at USD 53 per CCPS, supports NJ Bio's growth in the antibody-drug conjugate (ADC) CRDMO space and aligns with Cohance's strategic focus on high-growth biopharmaceutical services. The transaction is classified as a related-party transaction under SEBI regulations and will be completed before the end of September 2026.
About Cohance Lifesciences Ltd (COHANCE)
Healthcare ยท Pharmaceuticals ยท Listed on BSE
๐ก Get AI alerts when COHANCE files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track COHANCE โ Free๐ก Ask AI about this filing
๐ More COHANCE filings
- Announcement โ 28 September 2026Cohance Lifesciences Ltd announced that its trading window closes on 1 October 2026 for insiders and...
- Announcement โ 21 September 2026Cohance Lifesciences announced that the USFDA inspected its API facility in Andhra Pradesh from Sept...
- ๐ก Voting Results โ 17 September 2026Cohance Lifesciences held its 8th Annual General Meeting on 17 September 2026 via video conference, ...
- ๐ก Board Meeting โ 17 September 2026Cohance Lifesciences held its 8th Annual General Meeting on 17 September 2026 via video conference, ...
- ๐ด Announcement โ 17 September 2026Cohance Lifesciences Ltd announced it will attend the JP Morgan India Conference in Mumbai on 22 Sep...
๐ฅ Also filed on 18 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when COHANCE files new disclosures
Track COHANCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track COHANCE โ FreeFree account ยท 2 AI queries/day